Screener
Intellia Therapeutics NTLA Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Proceeds from sale of property and equipment | 90 | - |
| Purchases of marketable securities | (267,358) | (138,809) |
| Sales and maturities of marketable securities | 193,894 | 341,021 |
| Net cash (used in) provided by investing activities | (75,262) | 201,238 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Net proceeds from issuance of common stock through follow-on public offering | 194,580 | - |
| Net proceeds from issuance of common stock through at-the-market offerings | 33,569 | 13,415 |
| Proceeds from options exercised | 16 | - |
Item 1. Financial Statements
FAQ
- What is Intellia Therapeutics's investing cash flow?
- Intellia Therapeutics (NTLA) reported investing cash flow of -$141.57M in Q2 2026.
- How has Intellia Therapeutics's investing cash flow changed year-over-year?
- Intellia Therapeutics's investing cash flow decreased by 232.4% year-over-year, from $106.91M to -$141.57M.
- What is the long-term trend for Intellia Therapeutics's investing cash flow?
- Over 2 years (2021 to 2025), Intellia Therapeutics's investing cash flow has grown at a -35.6% compound annual growth rate (CAGR), from -$550.78M to $228.77M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Intellia Therapeutics's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude